Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Thyroid Tumor
and you are
between 20 and 60
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of the present study was to compare the effect of dexmedetomidine which is administered during emergence in adult patients undergoing elective thyroidectomy on smooth emergence form general anesthesia (reducing agitation or coughing, signs of hypertension or tachycardia, or etc.) and postoperative outcome (postoperative bleeding and hospital staying).

Provided treatments

  • Drug: Desflurane
  • Drug: Remifentanil
  • Procedure: Thyroidectomy
  • Other: Vital signs
  • Behavioral: Cough reflex
  • Behavioral: Ramsay Sedation Scale
  • Other: Extubation time and Recovery time
  • Behavioral: Visual analogue scale
  • Other: Postoperative bleeding
  • Other: Postoperative complications
  • Other: Time to remove drainage and duration of hospital staying
  • Drug: Dexmedetomidine
  • Drug: Normal saline
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02412150. The sponsor of the trial is Chosun University Hospital and it is looking for 120 volunteers for the current phase.
Official trial title:
Effect of Dexmedetomidine Infusion for Postoperative Outcome and Smooth Emergence After Thyroidectomy